Mesothelioma Research Programme Leicester
  • HOME
  • ABOUT US
    • RESEARCH TEAM
    • RESEARCH FUNDING
    • INDUSTRIAL PARTNERS
    • COLLABORATING INSTITUTIONS
    • USEFUL LINKS
  • WHAT WE DO
    • CLINICAL TRIALS
      • INDUSTRY TRIALS
        • ATOMIC
      • INVESTIGATOR LED STUDIES
        • MARS2
        • VIM
        • CONFIRM
        • FAK PD1 PHASE 1
        • MiST
        • MEDUSA
        • PEACE
    • TRANSLATIONAL RESEARCH
      • MESOTHELIOMA EVOLUTION
      • SPINDLE POISON PHARMACODYNAMICS
      • TARGETING CDKN2A-MTAP
      • MESOTHELIOMA STRATIFIED THERAPY (MiST)
  • PUBLICATIONS
    • SCIENTIFIC PAPERS
    • NEWS
  • CONTACT
    • DONATE
    • FOR HEALTH PROFESSIONALS
    • FOR PATIENTS
    • INDUSTRY
    • CAREER OPPORTUNITIES
    • PRIVACY POLICY
Select Page

European School Oncology e-session

Listen to Dean Fennell from University of Leicester and University Hospitals of Leicester NHS Trust talk to Margaret Hutka, St George’s University Hospital NHS Foundation Trust, London about ‘Current treatment, advances and research areas in mesothelioma’ at the European School Oncology e-session.
https://www.e-eso.net/sessions.do?methodcall=details&idegrandround=1190&Ticket=
Mesothelioma Research Programme Leicester University of Leicester University Hospitals of Leicester Leicester Precision Medicine Institute
Website Designed and Developed
by
Hyphen and Sandstar